Skip to content
10-Q

Quarterly Report

NxStage Medical, Inc.

0001333170-17-000016

← back to feed
Filed
Aug 8, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Aug 3, 2017 66.01M sh
Long Term Debt Q2 2017 · Jun 30, 2017 $553K
Long Term Debt Q2 2017 · Dec 31, 2016 $1.31M
Short Term Debt Q2 2017 · Jun 30, 2017 $95K
Short Term Debt Q2 2017 · Dec 31, 2016 $328K
Stockholders Equity Q2 2017 · Jun 30, 2017 $216.32M
Stockholders Equity Q2 2017 · Dec 31, 2016 $201.4M
Current Liabilities Q2 2017 · Jun 30, 2017 $46.51M
Current Liabilities Q2 2017 · Dec 31, 2016 $49.26M
Total Liabilities Q2 2017 · Jun 30, 2017 $112.41M
Total Liabilities Q2 2017 · Dec 31, 2016 $115.13M
Current Assets Q2 2017 · Jun 30, 2017 $155.47M
Current Assets Q2 2017 · Dec 31, 2016 $144.9M
Total Assets Q2 2017 · Jun 30, 2017 $328.57M
Total Assets Q2 2017 · Dec 31, 2016 $317.21M
Capex Q2 2017 · Jun 30, 2016 $5.47M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $58.46M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $59.07M
Sga Expense Q2 2017 · Jun 30, 2016 $8.51M
Sga Expense Q2 2017 · Jun 30, 2016 $16.54M
Rd Expense Q2 2017 · Jun 30, 2016 $7.96M
Rd Expense Q2 2017 · Jun 30, 2016 $15.12M
Net Income Q2 2017 · Jun 30, 2016 −$1.73M
Net Income Q2 2017 · Jun 30, 2016 −$3.01M
Operating Income Q2 2017 · Jun 30, 2016 −$1.18M
Operating Income Q2 2017 · Jun 30, 2016 −$2.16M
Gross Profit Q2 2017 · Jun 30, 2016 $38.42M
Gross Profit Q2 2017 · Jun 30, 2016 $74.94M
Cost Of Revenue Q2 2017 · Jun 30, 2016 $53.78M
Cost Of Revenue Q2 2017 · Jun 30, 2016 $106.47M